Search Results
Martine Piccart, MD, PhD: No Benefit in Extending Herceptin in HER2 Breast Cancer
Dr. Martine Piccart on HER2-targeted therapies in breast cancer
Martine Piccart: Patients with HER2 positive breast cancer
Dr. Piccart on Genomic Testing in Breast Cancer
Post-Op use of Herceptin, Part 1
HER2 Breast Cancer and Herceptin Use
Improved IDFS for breast cancer patients who received trastuzumab emtansine
Dr. Ron Bose on HER2 Gene Mutations in Breast Cancer
Dr. Aft on HER2- Tumors and HER2+ Disseminating Tumor Cells
Dr. Mark Pegram on Combining Trastuzumab and Pertuzumab
Dr. Hope Rugo on Trastuzumab Biosimilar in HER2-Positive Breast Cancer
Battling Breast Cancer with Pertuzumab and Herceptin
